3
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

The chemotherapy of onchocerciasis IV

Further trials with metrifonate

&
Pages 355-362 | Received 28 Aug 1979, Published online: 11 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

H. M. Gilles & K. Awadzi. (1991) The conquest of ‘river blindness’. Annals of Tropical Medicine & Parasitology 85:1, pages 97-101.
Read now
K. Awadzi, K. Y. Dadzie, H. Schulz-Key, H. M. Gilles, A. J. Fulford & M. A. Aziz. (1986) The chemotherapy of onchocerciasis XI A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in Northern Ghana. Annals of Tropical Medicine & Parasitology 80:4, pages 433-442.
Read now
K. Awadzi, K. Y. Dadzie, H. Shulz-Key, D. R. W. Haddock, H. M. Gilles & M. A. Aziz. (1985) The chemotherapy of onchocerciasis X.. Annals of Tropical Medicine & Parasitology 79:1, pages 63-78.
Read now
K. Awadzi, M. L'E. Orme, A. M. Breckenridge & H. M. Gilles. (1982) The chemotherapy of onchocerciasis IX. Annals of Tropical Medicine & Parasitology 76:5, pages 547-555.
Read now

Articles from other publishers (2)

I. Nir. 1982. 261 267 .
K. Awadzi, M. L'E. Orme, A. M. Breckenridge, D. Haddock & H. M. Gilles. (2009) Studies of Metrifonate in Onchocerciasis. Acta Pharmacologica et Toxicologica 49, pages 131-136.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.